Terminated OBSERVATIONAL NCT00847821

Observational Study Analyzing RNA Expression Of Endometrial Biopsy Samples From Placebo, Bazedoxifene/Conjugated Estrogens And Raloxifene

RNA Expression Analysis Of Endometrial Biopsies Comparing Placebo, Bazedoxifene/ Conjugated Estrogens And Raloxifene

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer

Interventions Bazedoxifene 10 mg/CE 0.45 mg Bazedoxifene 10 mg/CE 0.625 mg Bazedoxifene 20 mg/CE 0.45 mg Bazedoxifene 20 mg/CE 0.625 mg Bazedoxifene 40 mg/CE 0.45 mg Bazedoxifene 40 mg/CE 0.625 mg Placebo Raloxifene 60 mg

Updated 10 times since 2017 Last updated: Sep 3, 2010 Started: May 31, 2009 Primary completion: Aug 31, 2010 Completion: Aug 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

See termination reason in detailed description.

Other terminated trials from Wyeth is now a wholly owned subsidiary of Pfizer

See all terminations from Wyeth is now a wholly owned subsidiary of Pfizer

This observational or N/A phase trial investigates Postmenopause and is currently terminated or withdrawn. Wyeth is now a wholly owned subsidiary of Pfizer leads this study, which shows 10 recorded versions since 2009 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Terminated
Jul 2024 — Sep 2024 [monthly]

Terminated
Dec 2021 — Jul 2024 [monthly]

Terminated
Jan 2021 — Dec 2021 [monthly]

Terminated
Nov 2020 — Jan 2021 [monthly]

Terminated

▶ Show 5 earlier versions

Jun 2018 — Nov 2020 [monthly]

Terminated
May 2018 — Jun 2018 [monthly]

Terminated
Apr 2018 — May 2018 [monthly]

Terminated

Phase: PHASE3 → None
Aug 2017 — Apr 2018 [monthly]

Terminated PHASE3
Jan 2017 — Aug 2017 [monthly]

Terminated PHASE3

First recorded

May 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Wyeth is now a wholly owned subsidiary of Pfizer

Data source: Wyeth is now a wholly owned subsidiary of Pfizer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Billings, United States , Charlottesville, United States , Chaska, United States , Chicago, United States , Cincinnati, United States , Dallas, United States , Decatur, United States , Fort Myers, United States , Gainesville, United States , Greenville, United States and 12 more locations